Slingshot Insights is the first crowdfunded expert network and due diligence community. Members use our suite of tools to cut through the noise and Become the Smart Money. We provide you affordable access to Experts and Management Teams so that you can make informed investment decisions. By grouping investors around project ideas they care about, we pass along significant savings without compromising on quality.
I enjoy spending time day trading and analyzing the market. I’m always looking for a good swing or day trade, but mostly I’m focused on finding stocks that will hit big and up-list from the OTC to the big boards. Basically, almost all of my portfolio is traded daily, especially considering I tend to look over multiple market segments for trades instead of spending all my time on one section. I’ve been analyzing and trading stocks for over 9 years now, and I have a strong understanding of trends, as well as the knowledge to make smart trades.
Steven H. Goldman is a commercial litigation lawyer and senior partner in the Toronto law firm of Goldman Hine LLP. He is a former member of the board of directors of Tribute Pharmaceuticals Inc., a Canadian public pharmaceutical company which recently merged with Pozen Pharmaceuticals on February 5, 2016, and is now known as Aralez Pharmaceuticals (Nasdaq: ARLZ). He is currently on the board of directors of both Select Sands Corp. (TSX.V: SNS.V) as well as Comstock Metals Ltd. (TSX.V: CSL.V) which both trade on the TSX Venture exchange.